These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 18613848)

  • 1. Human regulatory T cells: role in autoimmune disease and therapeutic opportunities.
    Brusko TM; Putnam AL; Bluestone JA
    Immunol Rev; 2008 Jun; 223():371-90. PubMed ID: 18613848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory T cells and autoimmunity.
    Vila J; Isaacs JD; Anderson AE
    Curr Opin Hematol; 2009 Jul; 16(4):274-9. PubMed ID: 19417650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Manipulating regulatory T cells: a promising strategy to treat autoimmunity.
    Zhang D; Tu E; Kasagi S; Zanvit P; Chen Q; Chen W
    Immunotherapy; 2015; 7(11):1201-11. PubMed ID: 26568117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of naturally arising regulatory T cells in hematopoietic cell transplantation.
    Nguyen VH; Zeiser R; Negrin RS
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):995-1009. PubMed ID: 17084366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amelioration of acute graft-versus-host disease by adoptive transfer of ex vivo expanded human cord blood CD4+CD25+ forkhead box protein 3+ regulatory T cells is associated with the polarization of Treg/Th17 balance in a mouse model.
    Yang J; Fan H; Hao J; Ren Y; Chen L; Li G; Xie R; Yang Y; Qian K; Liu M
    Transfusion; 2012 Jun; 52(6):1333-47. PubMed ID: 22098312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory T cells as central regulators of both autoimmunity and B cell malignancy in New Zealand Black mice.
    Scaglione BJ; Salerno E; Gala K; Pan M; Langer JA; Mostowski HS; Bauer S; Marti G; Li Y; Tsiagbe VK; Raveche ES
    J Autoimmun; 2009 Feb; 32(1):14-23. PubMed ID: 19022624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host CD25+CD4+Foxp3+ regulatory T cells primed by anti-CD137 mAbs inhibit graft-versus-host disease.
    Kim J; Kim W; Kim HJ; Park S; Kim HA; Jung D; Choi HJ; Park SJ; Mittler RS; Cho HR; Kwon B
    Biol Blood Marrow Transplant; 2012 Jan; 18(1):44-54. PubMed ID: 21958951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen-specific regulatory T cells--ex vivo expansion and therapeutic potential.
    Masteller EL; Tang Q; Bluestone JA
    Semin Immunol; 2006 Apr; 18(2):103-10. PubMed ID: 16458533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adoptive cell therapy using in vitro generated human CD4+ CD25+ regulatory t cells with indirect allospecificity to promote donor-specific transplantation tolerance.
    Jiang S; Tsang J; Lechler RI
    Transplant Proc; 2006 Dec; 38(10):3199-201. PubMed ID: 17175221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CTLA-4 control over Foxp3+ regulatory T cell function.
    Wing K; Onishi Y; Prieto-Martin P; Yamaguchi T; Miyara M; Fehervari Z; Nomura T; Sakaguchi S
    Science; 2008 Oct; 322(5899):271-5. PubMed ID: 18845758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory T cells and tolerogenic dendritic cells: from basic biology to clinical applications.
    Rutella S; Lemoli RM
    Immunol Lett; 2004 Jun; 94(1-2):11-26. PubMed ID: 15234530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4+CD25+ Treg derived from hepatocellular carcinoma mice inhibits tumor immunity.
    Chen X; Du Y; Huang Z
    Immunol Lett; 2012; 148(1):83-9. PubMed ID: 23000301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cells and B cells cooperate in the generation of CD4(+)CD25(+)FOXP3(+) allogeneic T cells.
    Moore C; Sauma D; Reyes PA; Morales J; Rosemblatt M; Bono MR; Fierro JA
    Transplant Proc; 2010; 42(1):371-5. PubMed ID: 20172352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expanding and converting regulatory T cells: a horizon for immunotherapy.
    Khattar M; Chen W; Stepkowski SM
    Arch Immunol Ther Exp (Warsz); 2009; 57(3):199-204. PubMed ID: 19479206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4+ T-regulatory cells: toward therapy for human diseases.
    Allan SE; Broady R; Gregori S; Himmel ME; Locke N; Roncarolo MG; Bacchetta R; Levings MK
    Immunol Rev; 2008 Jun; 223():391-421. PubMed ID: 18613849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translating the concept of suppressor/regulatory T cells to clinical applications.
    Franco A; Albani S
    Int Rev Immunol; 2006; 25(1-2):27-47. PubMed ID: 16669133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic use of T regulatory cells.
    Verbsky JW
    Curr Opin Rheumatol; 2007 May; 19(3):252-8. PubMed ID: 17414951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interactions of dendritic cells with antigen-specific, regulatory T cells that suppress autoimmunity.
    Tarbell KV; Yamazaki S; Steinman RM
    Semin Immunol; 2006 Apr; 18(2):93-102. PubMed ID: 16469503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity.
    Yamazaki S; Inaba K; Tarbell KV; Steinman RM
    Immunol Rev; 2006 Aug; 212():314-29. PubMed ID: 16903923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired control of effector T cells by regulatory T cells: a clue to loss of oral tolerance and autoimmunity in celiac disease?
    Hmida NB; Ben Ahmed M; Moussa A; Rejeb MB; Said Y; Kourda N; Meresse B; Abdeladhim M; Louzir H; Cerf-Bensussan N
    Am J Gastroenterol; 2012 Apr; 107(4):604-11. PubMed ID: 22108452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.